Adjuvant Systemic Chemotherapy for Stages II and III Colon Cancer after Complete Resection: A Clinical Practice Guideline | Zendy

Brandon M. Meyers | Zendy; Roxanne Cosby | Zendy; Fayez A. Quereshy | Zendy; Derek J. Jonker | Zendy

Open Access

Adjuvant Systemic Chemotherapy for Stages II and III Colon Cancer after Complete Resection: A Clinical Practice Guideline

Author(s) -

Brandon M. Meyers,

Roxanne Cosby,

Fayez A. Quereshy,

Derek J. Jonker

Publication year - 2016

Publication title -

current oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.053

H-Index - 51

eISSN - 1718-7729

pISSN - 1198-0052

DOI - 10.3747/co.23.3330

Subject(s) - medicine , guideline , colorectal cancer , clinical practice , adjuvant chemotherapy , adjuvant , resection , cancer , systemic therapy , chemotherapy , oncology , general surgery , surgery , pathology , family medicine , breast cancer

Updated practice guidelines on adjuvant chemotherapy for completely resected colon cancer are lacking. In 2008, Cancer Care Ontario's Program in Evidence-Based Care developed a guideline on adjuvant therapy for stages ii and iii colon cancer. With newer regimens being assessed in this patient population and older agents being either abandoned because of non-effectiveness or replaced by agents that are more efficacious, a full update of the original guideline was undertaken.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research